Global Jasplakinolide Market Strategic Research Report

Scope of the Report

The global Jasplakinolide market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Jasplakinolide is a macrocyclic cyclodepsipeptide research reagent derived from marine sponge natural products and also accessible through organic synthesis. It has CAS number 102396-24-7, molecular formula C36H45BrN4O6, and molecular weight of approximately 709.67. Commercial Jasplakinolide is generally supplied as a white, off-white, or pale yellow solid, powder, or film in 50 microgram, 100 microgram, or custom packs. It requires low-temperature, dry, and light-protected storage and is commonly prepared in DMSO, ethanol, or methanol before use. Structurally, it contains a brominated indole unit, phenolic functionality, multiple amide bonds, and a lactone-containing macrocyclic scaffold. It is classified as a cell-permeable actin modulator. Manufacturing requires stringent stereochemical control, efficient macrocyclization, impurity removal, isomer control, and analytical confirmation by HPLC, MS, and NMR. Its mechanism is to bind filamentous actin at a site overlapping with phalloidin, promote actin nucleation and polymerization, and stabilize pre-existing actin filaments. It is mainly used in cytoskeleton biology, cell migration, endocytosis and exocytosis, neurodevelopment, cancer invasion, stem-cell differentiation, and live-cell imaging probe development, and is intended for research use only.

Market opportunities are mainly supported by the sustained need for cytoskeleton-modulating tools in basic life-science research. Studies on cell migration, cell morphology, endocytosis, exocytosis, neurodevelopment, immune-cell behavior, and cancer invasion require tool compounds that can rapidly and reproducibly perturb actin architecture. The product has a high unit price, low dosage, and project-driven repeat demand, making it suitable for high-purity micro-pack and custom-pack commercial models. As microscopy, organoid models, single-cell analysis, and early drug-discovery platforms expand, demand for standardized actin-modulating reagents is expected to increase gradually.

This report presents a comprehensive overview of the global Jasplakinolide market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• 50 Microgram Pack
• 100 Microgram Pack
• Bulk or Custom Pack

Segment by Purity Grade

• ≥95% HPLC Grade
• ≥97% HPLC Grade
• ≥98% High-Purity Grade
• ≥99% Ultra-High-Purity Grade

Segment by Application

• Experimental Study
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Jasplakinolide market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Experimental Study, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact